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Summary  27 
Biofunctional peptide ingredients should retain their stability following standard processing 28 
operations in food-based delivery vehicles. A boarfish protein hydrolysate, exhibiting anti-diabetic 29 
activity was subjected to a range of thermal treatments following incorporation into tomato-based 30 
soup and juice products. The dipeptidyl peptidase-IV (DPP-IV) inhibitory activity and peptide profile of 31 
the hydrolysate within the products were assessed before and after thermal treatment. The 32 
treatments applied had no effect on the DPP-IV inhibitory activity or peptide profile of the protein 33 
hydrolysate. The heat-treated (90°C x 1 min and 121°C x 42 s) juice-fortified beverage had microbial 34 
counts within the acceptable limits for consumption when stored at 4°C for 30 days. Furthermore, the 35 
hydrolysate within the beverage products was resistant to simulated gastrointestinal digestion (SGID) 36 
regardless of whether it was heat or non-heat treated, or stored for 30 days at 4°C. Therefore, tomato-37 
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1. Introduction 49 
There is an established consumer demand and a rapidly growing market for foods and/or food 50 
ingredients which provide health benefits beyond their basic nutritional properties, i.e., functional 51 
foods. Food proteins contain a diverse array of short peptides (2-20 amino acids) which are released 52 
during food processing (by enzymatic hydrolysis or fermentation) or during gastrointestinal transit 53 
with the potential to beneficially modulate human health (Harnedy & FitzGerald, 2012 & 2013). 54 
Protein hydrolysates or peptides mediating such properties have potential applications as functional 55 
food ingredients. The selection of an appropriate food vehicle for delivery of a functional ingredient is 56 
of major importance as foods contain many components that can interact with peptides and mediate 57 
a reduction in peptide bioactivity and bioavailability (Kamdem & Tsopmo, 2019). Furthermore, one of 58 
the primary challenges associated with the incorporation of bioactive peptides into commercial 59 
products is the susceptibility of the peptides to modification during conventional food processing 60 
operations, e.g., thermal treatment. Due to its ability to inactivate microorganisms and spoilage 61 
enzymes thermal treatment is the most commonly used processing operation in the food industry 62 
(Rawson et al., 2011). Thermal treatment of protein/peptide containing foods may induce substantial 63 
changes in the structure of the protein or protein hydrolysate. These include protein/peptide 64 
denaturation or aggregation, interactions between protein/peptide/amino acids and other 65 
components within the food matrix e.g., the generation of Maillard reaction products, destruction of 66 
heat sensitive amino acids and the formation of dehydroalanine-derived cross-links (Singh, 1991; 67 
Korhonen et al., 1998; Gerrard, 2002; Vasbinder et al., 2003; Rao et al., 2016).   68 
To date, information regarding the influence of routinely used industrial processing and storage 69 
conditions on the bioactivity, in particular the potential anti-diabetic activity, of protein hydrolysates 70 
when incorporated into different food matrices is limited. The majority of the research reported to 71 
date in this area has been performed with aqueous solutions of protein hydrolysates/peptides and 72 
not with delivery vehicles containing the functional protein hydrolysate/peptide ingredient (Hwang, 73 
2010; Wu et al., 2014; Zhu et al., 2014; Lai et al., 2016; Wali et al., 2017; Rivero-Pino et al. 2020).  74 
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In a previous study we have shown that a boarfish-derived protein hydrolysate (BPH) exhibits 75 
promising anti-diabetic activity both in vitro (DPP-IV inhibition and pancreatic β cells and 76 
enteroendocrine cells in culture) and in a small animal study (Parthsarathy et al., 2019). While the 77 
hydrolysate had no effect on biomarkers of glycaemic control and satiety at the dose given in a 78 
randomised controlled human intervention crossover study with healthy adults, a significant increase 79 
in satiety rating was reported at 180 min following consumption of a beverage fortified with the 80 
hydrolysate compared to the unfortified control (Crowe et al., 2018). Furthermore, a number of 81 
peptides with in vitro and in situ cell-based (Caco-2) DPP-IV inhibitory activity and in situ insulin 82 
secretory activity have been identified within the BPH  (Harnedy-Rothwell et al., 2020). Based on the 83 
above results the BPH has potential applications as an antidiabetic functional food ingredient.  84 
In order for protein hydrolysates to be utilised as functional food ingredients they must retain their 85 
activity when incorporated into food matrices which experience various processing and storage 86 
conditions. Therefore, this study determined the effect of thermal treatment (pasteurisation and 87 
sterilisation) and storage conditions on the in vitro dipeptidyl peptidase-IV (DPP-IV) inhibitory activity 88 
of a BPH when incorporated into two tomato-based products (a soup and a beverage). Furthermore, 89 
the effect of fortification of a tomato-based matrix, heat treatment and storage conditions on the 90 
susceptibility of the BPH to simulated gastrointestinal digestion (SGID) was investigated. 91 
 92 
2. Materials and methods  93 
2.1. Materials and chemicals 94 
H-Gly-Pro-7-amino-4–methyl coumarin (AMC) and Diprotin A were obtained from Bachem 95 
Feinchemikalien (Bubendorf, Switzerland). Kjeldahl catalyst tablets were obtained from VWR 96 
International (Dublin, Ireland). Low nitrogen sodium hydroxide (40% (w/v)) was obtained from TE 97 
Laboratories Ltd. (Carlow, Ireland). Sulphuric acid (low nitrogen) was purchased from Lennox 98 
Laboratory Supplies Ltd (Dublin, Ireland). Corolase PP was provided by AB Enzymes (Darmstadt, 99 
Germany) and BC pepsin was kindly provided by Biocatalysts Ltd (Cardiff, Wales, United Kingdom). All 100 
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other reagents including Alcalase® 2.4L and Flavourzyme® 500L and DPP-IV, from porcine kidney (≥10 101 
units/mg protein) were supplied by Sigma Chemical Company Ltd. (Wicklow, Ireland). Samples of 102 
minced deboned boarfish (Capros aper) meat was kindly provided by Bio-Marine Ingredients Ireland, 103 
Ltd., Lough Egish Food Park, Castleblaney, Co. Monaghan, Ireland. A tomato based chilli soup, 104 
containing tomatoes, red peppers, red chillies and chilli flakes, garlic, olive oil, fresh basil and 105 
vegetable stock was prepared at Ulster University, Coleraine, Co. Derry, Northern Ireland. 106 
 107 
2.2. Generation of BPH at semi-pilot scale  108 
The BPH was generated with Alcalase 2.4L and Flavourzyme 500L at semi-pilot scale as described 109 
previously (Harnedy-Rothwell et al., 2020).  110 
 111 
2.3 Quantification of protein equivalent content  112 
The protein equivalent content of the BPH was measured by the macro-Kjeldahl procedure (Connolly 113 
et al., 2013) using a nitrogen to protein conversion factor of 6.25 (Kristinsson and Rasco, 2000).   114 
 115 
2.4. Preparation, processing and storage of tomato soup and juice products and control samples. 116 
Tomato based chilli soup samples with (5.83% (w/w)) and without BPH were prepared. An equivalent 117 
aqueous solution of the hydrolysate was also prepared (e.g., 5.83 % (w/w)) at pH 5.26) and used as a 118 
control. The samples containing the hydrolysate were heated at 80 and 95 oC for 3 min and at 121 oC 119 
for 42 s (sterilisation conditions) in an oil bath and were then rapidly cooled by placing on ice (Gould, 120 
1992). A second set of samples which received no heat treatment was also prepared. 121 
V8® vegetable juice (Kelsen A/S Group, Denmark) was purchased from a health food shop (Limerick, 122 
Ireland). Vegetable juice samples with and without BPH (2.33% (w/v) powder equivalent to 1.64% 123 
(w/v) protein/hydrolysate) were prepared. An equivalent aqueous solution containing the hydrolysate 124 
was also prepared (e.g., 2.33% (w/w) and pH 4.71) and used as a control. The samples containing the 125 
hydrolysate were heated at 90 oC for 1 min (pasteurisation conditions) and 121 oC for 42 s (sterilisation 126 
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conditions) in an oil bath and then rapidly cooled by placing on ice (Gould, 1992). Samples were stored 127 
for 30 days at 4 oC and were subsampled on Day 0, 1, 3, 7, 10, 15, 20, 25 and 30. A second set of 128 
samples, which received no heat treatment (and which were not stored for 30 days at 4 oC) were also 129 
prepared to investigate the effect of heat treatment on the DPP-IV inhibitory activity and peptide 130 
profile of the hydrolysate on Day 0.  131 
 132 
2.5. Simulated gastrointestinal digestion (SGID)  133 
SGID was performed as described by Walsh et al. (2004) with modifications. In brief, the pH of the 134 
water and soup/juice products containing 2.0 % (w/v) hydrolysate was altered to pH 2.0 using 6M HCl 135 
and were then incubated at 37˚C for 90 min with pepsin at an E:S of 2.5% (w/w). The pH of the samples 136 
were then adjusted to pH 7.0 using 5N NaOH and incubated at 37˚C with Corolase PP (E:S of 1.0 % 137 
(w/w)) for a further 150 min. Enzyme activity was inactivated by heating at 80˚C for 20 min. 138 
 139 
2.6. Peptide profile 140 
The peptide profiles of the samples were determined by reverse-phase ultra-performance liquid 141 
chromatography (RP-UPLC) as described by  Nongonierma & FitzGerald (2012)  at a flow rate of 0.2 142 
ml/min. 143 
 144 
2.7. Quantification of DPP- IV inhibitory activity 145 
DPP-IV inhibition was determined as described by Harnedy et al. (2015). All assays were performed in 146 
triplicate (n=3). Activity results were expressed as % inhibition at a BPH concentration of 2 mg/ml. 147 
Diprotin A was used as a positive control.  148 
 149 
2.8. Microbial analysis 150 
Samples of fortified juice which underwent thermal treatment and were stored at 4˚C for 30 days, 151 
were diluted using Ringers solution and plated onto standard plate count agar (PCA) to determine the 152 
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total plate count (TPC). The plates were incubated at 37˚C for 48 h and the colonies were then 153 
counted.  154 
 155 
2.9. Statistical analysis 156 
All statistical analysis was performed using the SPSS statistical software program (Version 22, IBM Inc., 157 
Chicago, IL, USA). Statistical significance (p<0.05) was determined using one-way analysis of variance 158 
(ANOVA) followed by Tukey’s and Games–Howell post-hoc tests, where applicable.  159 
 160 
3.0 Results and Discussion 161 
3.1 Selection of hydrolysate delivery vehicle and assessment of thermal heat treatment conditions  162 
The nature and type of food products that can act as delivery vehicles for biofunctional peptide 163 
ingredients depends to a large extent on the stability of the active peptides within the food matrix 164 
selected, the processing conditions employed and the stability of the peptides during storage. Two 165 
tomato-based products, a soup and juice which in general undergo pasteurisation and sterilisation 166 
treatments to enhance shelf-life, were selected as the delivery vehicles in this study. Selection of these 167 
formats was based on the following: (a) the savoury nature of the soup/juice could mask the 168 
odour/taste associated with the BPH, (b) the low glycaemic load (GL: 4 for V8® vegetable juice 169 
(Atkinson et al., 2008)) and negligible lipid content makes it suitable for delivery of a functional 170 
ingredient for glycaemic management and (c) its intrinsically low protein content (approximately 0.9 171 
% (w/v)). The protein equivalent content of the BPH generated at semi-pilot scale used herein was 172 
71.35 % (w/w). The quantity of hydrolysate incorporated into the soup and juice product in this study 173 
was based on the amount of hydrolysate powder (3.5g) which mediated an anti-diabetic response in 174 
vivo (Parthsarathy et al., 2019). Taking into account a typical serving of soup (60 ml) and juice (150 175 
ml), the hydrolysate fortification level utilised was 5.83 and 2.33 % (w/v) for the soup and juice 176 
product, respectively. This in turn equates to a protein equivalent content of 4.16 and 1.64 % (w/v), 177 
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respectively, and an overall dose of 2.50 and 2.46 g protein equivalent, respectively. The fortified 178 
tomato-based soup sample utilised in this study was the same as that used in a randomised controlled 179 
human intervention crossover study designed to assess the effect of hydrolysate intake (3.50 g) 180 
equivalent to 2.50 g protein on biomarkers of glycaemic control and satiety in healthy adults (Crowe 181 
et al., 2018). Thermal processing is conventionally used in the food industry to inactivate 182 
microorganisms and enzymes and to thereby extend the shelf-life of food products.  In the tomato 183 
processing industry, common conditions used for pasteurisation and sterilisation of tomato-based 184 
products involve heating at 90o C x 1 min and 121 oC x 42 s, respectively (Gould, 1992). Furthermore, 185 
the recommended instructions for heating tomato-based soup products prior to consumption is to 186 
heat at 80o C x 3 min, however, the common practice of heating soup involves heating at 95o C x 3 min. 187 
Studies were therefore performed to determine if the routine thermal treatment conditions used in 188 
industry to preserve tomato-based products (soup and juice) and the suggested or actual conditions 189 
used to heat soup prior to consumption had an effect on the in vitro DPP-IV inhibitory activity and 190 
peptide profile of the BPH when incorporated into these delivery formats. 191 
 192 
3.2 Effect of heat treatment on the DPP-IV inhibitory activity and peptide profiles of the boarfish 193 
hydrolysate when incorporated into tomato-based soup and juice products. 194 
As shown in Tables 1 and 2, none of heat treatments employed/tested had any effect on the DPP-IV 195 
inhibitory activity of the aqueous BPH solutions. Furthermore, no differences were observed in the 196 
RP-UPLC profiles of the aqueous hydrolysate solutions irrespective of whether they were subjected or 197 
not subjected to thermal treatment (data not shown). This indicates that the hydrolysate was 198 
thermostable and that the recommended pasteurization (90°C x 1 min) and the recommended and 199 
commonly used reheating conditions for soup (80o C x 3 min and 95o C x 3 min, respectively) and the 200 
sterilization (121°C x 42 s) conditions employed had no effect on the hydrolysate peptide profile and 201 
the DPP-IV inhibitory activity.  202 
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The results reported herein are consistent with the findings of Lai et al. (2016), who showed that 203 
walnut protein hydrolysates were stable and retained their antioxidant activity following heat 204 
treatment at 65°C x 30 min and 121°C x 20 min. Furthermore, the bioactivity exhibited by rapeseed, 205 
tuna cooking juice and bovine casein-derived protein hydrolysate/peptides was reported to be stable 206 
when subjected to temperatures in the range 0-100 °C (Hwang, 2010; Wu et al., 2014; Wali et al., 207 
2017). However, the angiotensin converting enzyme inhibitory activity mediated by the rapeseed and 208 
casein-derived protein hydrolysate/peptides significantly decreased when heated at temperatures 209 
above 100 °C. However, it should be noted that the duration of thermal treatment was 1 and 2 h, 210 
respectively (Wu et al., 2014; Wali et al., 2017).  Antioxidant peptides derived from Jinhua ham were 211 
shown to be less thermostable than the protein hydrolysate/peptides described above (Zhu et al., 212 
2014). The ham peptides were shown to lose activity when heated above 60°C.  213 
A similar result to that observed with aqueous hydrolysate solutions herein was seen with the tomato-214 
based soup and juice products containing the BPH. The thermal treatments employed were shown to 215 
have no effect on the DPP-IV inhibitory activity (Table 1 and 2). As shown in Table 1 no significant 216 
difference (p>0.05) was observed in the in vitro DPP-IV inhibitory activity of the fortified soup samples 217 
which underwent no heat treatment (72.29 ± 1.18 %) or which were heated at 80 o C x 3 min (72.34 ± 218 
1.71 %), 95o C x 3 min (73.47 ± 2.97 %) and 121°C x 42 s (72.45 ± 2.66 %) when tested at 2 mg/ml. 219 
Similarly, no significant difference was observed in the DPP-IV inhibitory activity (Table 2) of the 220 
fortified juice samples which received no heat treatment (74.23 ± 2.56 %) or were treated at 90o C x 1 221 
min (73.67 ± 4.39 %) and 121°C x 42 s (72.74 ± 4.63 %). Similar RP-UPLC profiles were observed for the 222 
non-heat treated aqueous and tomato beverage samples containing the hydrolysate (data not shown). 223 
This indicates that there was no negative interaction between the tomato-based matrix and the 224 
hydrolysate. Furthermore, no differences were observed in the RP-UPLC profiles of the hydrolysate 225 
incorporated into soup and juice matrices pre- and post-heat treatment (Fig 1a and 2). This indicates 226 
that that there was no interaction between the tomato-based matrix and the hydrolysate during the 227 
heat treatments employed. This suggests that the biofunctional BPH is stable under the thermal 228 
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conditions tested and could be incorporated into a tomato-based matrix and withstand the standard 229 
industrial thermal processing conditions required for the preservation and reheating of these 230 
commercially available products. 231 
Food products commonly undergo heat treatment to improve their safety and/or extent their shelf-232 
life (Rawson et al., 2011). Therefore, the effect of storage (4 °C for 30 days) on the bioactivity and the 233 
peptide profile of heat treated (90o C x 1 min and 121°C x 42 s) hydrolysate containing juice samples 234 
was assessed. A similar study with an aqueous suspension of the hydrolysate was performed for 235 
comparative purposes. Firstly, microbial analysis of the fortified juice samples which underwent 236 
pasteurisation and sterilisation and which was stored for 30 days at 4 °C shows that the heat 237 
treatments applied were effective in inhibiting the growth of potential spoilage organisms during the 238 
course of 30 days’ storage. The sterilised sample was free from bacteria, while the pasteurised sample 239 
had a total count of 400 cfu/ml at day 30, which is within the acceptable limits for human consumption 240 
(FSA, 2016). As shown in Table 2, the DPP-IV inhibitory activity of the aqueous solution did not change 241 
over the storage period assessed irrespective of the thermal treatment applied. Furthermore, the DPP-242 
IV inhibitory activity exhibited by the juice product fortified with the hydrolysate also remained the 243 
same over the storage period assessed again irrespective of the thermal treatment applied. This 244 
indicates that the hydrolysate was stable over the storage period assessed (as seen with the aqueous 245 
hydrolysate solution) and that the juice vehicle had no negative effect on the in vitro anti-diabetic 246 
activity of the hydrolysates during storage. This was also seen following RP-UPLC analysis of the 247 
samples where no difference was observed in the peptide profiles obtained for the thermally and non-248 
thermally treated fortified juice samples stored for 30 days at 4 °C (Figure 2). Similar results were 249 
reported for a round scad protein hydrolysate stored at 4 and 25 °C for 6 weeks where Thiansilakul et 250 
al. (2007) showed that the hydrolysate retained its antioxidant activity during the storage period. 251 
While a small decrease in DPPH radical-scavenging activity was observed within the first week of 252 
storage at 4 and 25 °C, no further change in DPPH radical-scavenging activity was observed thereafter. 253 
No significant difference in the reducing power or the metal-chelating activity of the protein 254 
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hydrolysate was observed within the first 2 weeks of storage at 4 and 25 °C, however, a slight decrease 255 
in activity was observed between weeks 2-6. It was shown that the antioxidant activity exhibited by 256 
the round scad protein hydrolysate was more stable when stored at 4 than at 25 °C (Thiansilakul et 257 
al., 2007).  Milk protein derived antihypertensive peptides, RYLGY and AYFYPEL, were also shown to 258 
be stable when incorporated into a yoghurt product and stored at 4 °C for 28 days (Contreras et al., 259 
2011).  260 
While the storage temperature selected in this study (4 °C) represents that commonly utilised for a 261 
pasteurised product, a sterilised product would usually be stored at room temperature and for a 262 
longer period of time (>30 days). It would be interesting to investigate if the sterilised hydrolysate 263 
containing product could retain their activity following storage at ambient temperature for extended 264 
periods of storage.  265 
 266 
3.3 Effect of SGID on the DPP-IV inhibitory activity and RP-UPLC profiles of a boarfish hydrolysate 267 
when incorporated into tomato-based soup and juice products  268 
In order to exert a biological effect in vivo, the integrity of active peptides within the food vehicle must 269 
be maintained during digestion and transport. In a previous study we have shown that the BPH was 270 
resistant to SGID (Harnedy-Rothwell et al., 2020). This was also observed herein in Table 1 where no 271 
significant differences (P>0.05) were observed in the DPP-IV inhibitory activity by the non-heat treated 272 
aqueous hydrolysate samples pre- and post-SGID.  273 
As shown in Table 1 and 2, no significant differences (P>0.05) were observed in the DPP-IV inhibitory 274 
activity pre- and post-SGID for the non-heat and heat-treated soup and juice samples containing the 275 
hydrolysate.  The fact that similar DPP-IV inhibitory activity and peptide profiles were observed for the 276 
non-heat treated soup and juice samples before and after SGID (Tables 1 and 2, Figures 1, 2 and 3) 277 
indicates that components within the tomato-based vehicles did not alter the hydrolysate’s resistance 278 
to SGID. Furthermore, similar results were seen with the heat treated soup and juice samples, which 279 
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would indicate that the heat treatments employed had no effect on the in vitro digestion status of the 280 
hydrolysate (Tables 1 and 2, Figures 1, 2 and 3).  281 
To our knowledge there is no information available on the effect of food formulation and processing 282 
on the SGID status of foods containing protein hydrolysates. However, it is possible that the bioactivity 283 
of other hydrolysates, when incorporated into a food matrix and/or subjected to various processing 284 
conditions may be improved or reduced following SGID. Modifications to peptide structure induced 285 
during processing may alter the digestibility of the peptides producing breakdown products which 286 
may be more or less potent than the original peptides. Furthermore, peptides that would otherwise 287 
be rendered inactive by exposure to the SGID enzymes when taken in aqueous format may be 288 
protected when incorporated in a food matrix. However, in vivo investigations would be required to 289 
confirm the observations herein. 290 
 291 
4. Conclusion 292 
This study has shown that the thermal processing and storage conditions used routinely to enhance 293 
the shelf-life of tomato-based juice and soup products had no effect on the in vitro anti-diabetic 294 
activity and peptide profile of a BPH incorporated therein. Furthermore, the tomato-based juice and 295 
soup vehicles and the processing and storage conditions assessed had no effect on the SGID status of 296 
the BPH. Therefore, the present study highlights the potential of tomato-based products as vehicles 297 
for delivery of protein hydrolysates. While preliminary sensory analyses performed prior to the human 298 
study indicated that the savoury flavour of the tomato-based chilli soup had the ability to mask the 299 
fishy taste/odour of the BPH within, comprehensive organoleptic and acceptability studies need to be 300 
performed to ensure that the fortified products are accepted by a broad range of consumers.  It must 301 
also be noted that while the tomato-based beverages used herein had low glycaemic loads, in general, 302 
commercially produced tomato soup can contain sugar which would add significantly to the glycaemic 303 
load and render it unsuitable as a delivery vehicle for antidiabetic agents. Furthermore, fortification 304 
of foods with the BPH presents a unique opportunity to increase the commercial value of a low-value 305 
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underutilised fish species through the production of nutritionally and biofunctionally enriched 306 
beverage products. 307 
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Table 1. Impact of different thermal treatments and simulated gastrointestinal digestion (SGID) on the 425 
dipeptidyl peptidase-IV (DPP-IV) inhibitory activity of a boarfish (Capros aper) protein hydrolysate 426 
(BPH) in an aqueous and soup matrix. 427 
 428 
Sample Heat treatment DPP-IV inhibition (%) 





None 63.27 ± 1.18
a





C  x 3 min 62.13 ± 1.96
a





C  x 3 min 63.72 ± 2.39
a





C x  42 s 61.56 ± 1.02
a 61.68 ± 1.71a* 
BPH + Soup 
 
None 72.79 ± 1.18
a





C  x 3 min 72.34 ± 1.71
a





C x 3 min 73.47 ± 2.97
a





C x  42 s 72.45 ± 2.66





















C  x 42 s 10.01 ± 1.04
a nd 
Mean ± SD (n=3). The concentration of hydrolysate used in all cases was 2 mg/ml. For each sample 429 
values with different letters are significantly different at p<0.05. *: indicates that no significant 430 

















Table 2. Impact of heat treatment, storage time and simulated gastrointestinal digestion (SGID) on 446 
the dipeptidyl peptidase-IV (DPP-IV) inhibitory activity of a boarfish (Capros aper) protein hydrolysate 447 
(BPH) in an aqueous and tomato-based juice matrix. 448 
 449 
Sample Heat treatment  Storage time 
(Days) 
DPP-IV inhibition (%) 
   Before SGID After SGID 
BPH + H2O  
 
None  0 61.72 ± 2.47
a 66.66 ± 2.71a* 
90 
o
C x 1 min  0 63.05 ± 3.71
a 67.59 ± 1.06a* 
90 
o
C x 1 min  15 62.49 ± 3.60
a 64.81 ± 1.49a* 
90 
o
C x 1 min  30 64.21 ± 1.56
a 66.58 ± 1.94a* 
121 
o
C x 42 s  0 62.80 ± 1.44
a 64.26 ± 1.72a* 
121 
o
C x 42 s  15 63.00 ± 2.39
a 66.98 ± 0.63a* 
121 
o
C x 42 s 
 30 62.09 ± 3.61a 66.30 ± 0.34a* 
BPH + Juice   
 
None  0 74.23 ± 2.56a 80.34 ± 3.03a* 
90 
o
C x 1 min  0 73.67 ± 4.39
a 76.23 ± 1.25a* 
90 
o
C x 1 min  15 73.93 ± 2.52
a 76.46 ± 1.91a* 
90 
o
C x 1 min  30 74.40 ± 2.85
a 77.58 ± 1.85a* 
121 
o
C x 42 s  0 72.74 ± 4.63
a 75.03 ± 1.60a* 
121 
o
C x 42 s  15 74.49 ± 4.08
a 75.73 ± 2.38a* 
121 
o
C x 42 s  30 75.56 ± 3.21
a 80.39 ± 1.91a* 
Juice + H2O 
 
None  0 31.46 ± 0.42a nd 
90 
o




C x 1 min 
 15 31.12 ± 2.84a nd 
 90 
o












C x 42 s  30 29.85 ± 3.16
a nd 
Mean ± SD (n=3), The concentration of hydrolysate used in all cases was 2 mg/ml. For each sample 450 
values with different letters are significantly different p<0.05. *: indicates that no significant difference 451 














Fig. 1. Reverse-phase ultra-performance liquid chromatography profiles of soup samples fortified with a boarfish (Capros aper) protein hydrolysate (5.83 % 464 











Fig. 2. Reverse-phase ultra-performance liquid chromatography profiles of juice samples containing a 474 
boarfish (Capros aper) protein hydrolysate (2.33% (w/v)) following two different heat treatments (90 475 
oC x 1 min and 121 oC x 42 s) and subsequent storage at 4 oC. Control: No heat treatment, D0: Day 0, 476 




















Fig. 3. Reverse-phase ultra-performance liquid chromatography profiles of juice samples containing a 495 
boarfish (Capros aper) protein hydrolysate (2.33% (w/v)) before and after simulated gastrointestinal 496 
digestion (SGID) following different heat treatments (a) 90 
o
C x 1 min and (b) 121 
o
C x 42 s and 497 
subsequent storage at 4 oC for 15 (D15) and 30 (D30) days.  498 
 499 
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 501 
 502 
 503 
 504 
 505 
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